Kintara Therapeutics, Inc. (KTRA) Social Stream



Kintara Therapeutics, Inc. (KTRA): $0.21

-0.01 (-5.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add KTRA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 471

in industry

Kintara Therapeutics Inc (KTRA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering KTRA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-16 3 $6 $3 $4.562 $0.398 1046.23%
2021-12-02 3 $6 $3 $4.75 $0.398 1093.47%
2022-02-15 3 $5 $3 $4 $0.398 905.03%

The Trend in the Analyst Price Target


Over the past 12 months, KTRA's average price target has gone down $1.5.

KTRA reports an average of 489.25% for its upside potential over the past 42 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 0 7 5 5.810 1.520 282.24%
2021-06-24 0 7 5 5.810 2.400 142.08%
2021-10-22 3 6 3 4.562 0.910 401.32%
2021-11-16 3 6 3 4.500 0.842 434.44%
2022-02-15 3 5 3 4.000 0.466 758.37%

KTRA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 26 weeks, KTRA's average broker recommendation rating improved by 1.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Kintara Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 395.92% of them.
  • Kintara Therapeutics Inc's average analyst price target is greater than 8.83% of all US stocks.
  • In terms of how Kintara Therapeutics Inc fares relative to Healthcare stocks, note that its number of analysts covering the stock is greater than 50.28% of that group.
  • In terms of how Kintara Therapeutics Inc fares relative to stocks in the micro market cap category, note that its variance in analysts' estimates is lower than -208.57% of that group.

Stocks similar to Kintara Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are JAGX, IPA, and IOBT.

Is KTRA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4502 seconds.